In vitro cytobiological effects of human herpesviruses 6 and 7: Immunohistological monitoring of apoptosis, differentiation and cell proliferation

Anticancer Research

Volumn 17, Issue 6 D, 1997, Pages 4623-4632

  Kirn, Ekkehard ^a   Krueger, Elke ^b   Boehmer, Sabine ^a   Klussmann, Jens Peter ^a   Krueger, Gerhard R F ^a,c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Cell proliferation; Cytokines; HHV 6; HHV 7; Membrane receptors

Indexed keywords

CYCLIN D1; CYCLINE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MEMBRANE RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; RAF PROTEIN; VIRUS ANTIGEN; VIRUS DNA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; IMMUNOHISTOLOGY; NONHUMAN; ONCOGENE C FOS; ONCOGENE C H RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TARGET CELL; VIRUS REPLICATION;

ANTIGENS, VIRAL; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, VIRAL; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA, VIRAL; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-RAF; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VIRUS REPLICATION;

EID: 0031409308     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, Gallo R: Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234: 596-601, 1986.
2. Salahuddin SZ, Kelley AS, Krueger GRF, Josephs SF, Gupta S, Ablashi DV: Human herpesvirus-6 (HHV-6) in diseases. Clin Diagn Virol 1: 81-100, 1993.
3. Krueger GRF, Klueppelberg U, Hoffmann A, Ablashi DV: Clinical correlates of infection with human herpesvirus-6. In Vivo 8: 457-486, 1994.
4. Kikuchi M, Sumiyoshi Y, Minamishima Y: Kikuchi's disease (histiocytic necrotizing lymphadenitis). In: Ablashi DV, Krueger GRF, Salahuddin SZ: Human Herpesviras-6. Epidemiology, molecular biology and clinical pathology. Elsevier Sci Publ, Amsterdam pp. 175-183, 1992.
5. Torelli G, Mascara R, Lippi M, Selleri L: Human herpesvirus-6 in human lymphomas: Identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction. Amer Soc Hematol 77: 2251-2258, 1991.
6. Krueger GRF, Guenther A, Knuefermann R, Klueppelberg U, Luka J, Pearson GR, Ablashi DV, Juecker M, Tesch H: Human herpesvirus-6 (HHV-6) in Hodgkin's disease: cellular expression of viral antigens as compared to oncogens met and fes, tumor suppressor gene product p53, and interleukins 2 and 6. In Vivo 8: 501-516, 1994.
7. Frenkel N, Schirmer EC, Wyatt LS, Katsafanas G, Roffman E, Danovich RM, June CH: Isolation of a new herpesvirus from CD4+ T cells. Proc Natl Acad Sci USA 87: 748-752, 1990.
8. Berneman ZN, Ablashi DV, Li G, Eger-Fletcher M, Reitz MS Jr, Hung CL, Brus 1, Komaroff AL, Gallo RC: Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci USA 89: 10552-10556, 1992.
9. Krueger GRF, Koch B, Berneman Z: Seroepidemiology of human herpesvirus-7 (HHV-7) in healthy blood donors from nine countries. FASEB J 9: A145, 1995.
10. Tanaka K, Kondo T, Torigoe S, Okada S, Mukai T, Yamanishi K: Human herpesvirus-7: another causal agent for roseola (exanthem subitum), J Pediat 125: 1-5, 1994.
11. Kramarsky B, Sander C: Electron microscopy of human herpesvirus-6 (HHV-6).1Q: Ablashi DV, Krueger GRF, Salahuddin SZ: Human Herpesvirus-6: Epidemiology, molecular biology and clinical pathology. Elsevier Sci Publ, Amsterdam pp. 59-68, 1992.
12. Klussmann JP, Krueger E, Sloots T, Berneman Z, Arnold G, Krueger GRF: Ultrastructural study of human herpesvirus-7 replication in tissue culture. Virchows Archiv 430: 417-426, 1997.
13. Shen Y, Shenk TE: Viruses and apoptosis. Curr Opinion Genetics Developm 5: 105-111, 1995.
14. Steller H: Mechanisms and genes of cellular suicide. Science 267: 1445-1449, 1995.
15. Schwartz SM, Bennett MR: Death by any other name. Am J Pathol 147: 229-234, 1995.
16. Eastman A: Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis. Sem Cancer Biol 6: 45-52, 1995.
17. Cordon-Cardo C: Mutation of cell cycle regulators. Am J Pathol 147: 545-560, 1995.
18. Wyllie AH: The genetic regulation of apoptosis. Curr opinion Genet Dev 5: 97-104, 1995.
19. Kroemer G, Petit P, Zamzami N, Vayssiere JL, Mignotte B: The biochemistry of programmed cell death. FASEB J 9: 1277-1287, 1995.
20. Ablashi DV, Luso P, Hung CL, Salahuddin SZ, Josephs SF, Liana T, Kramarsky B, Biberfeld P, Markham PD, Gallo RC: Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6). Int J Cancer 42: 787-791, 1988.
21. Krueger GRF, Ablashi DV, Josephs SF, Salahuddin SZ, Lembke U, Ramon A, Bertram G: Clinical indication and diagnostic techniques of human herpesvirus 6 (HHV-6) infection. In Vivo 5: 287-296, 1991.
22. Krueger GRF, Sander C, Hoffmann A, Barth A, Koch B, Braun M: Isolation of human herpesvirus 6 (HHV-6) from patiens with collagen vascular disease. In Vivo 5: 217-226, 1991.
23. Ablashi DV, Balachandran N, Josephs SF, Hung CL, Krueger GRF, Kramarsky B, Salahuddin SZ, Gallo RC: Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus 6 isolates. Virology 184: 545-552, 1991.
24. Josephs SF, Salahudin SZ, Ablashi DV, Schachter F, Wong-Staal F, Gallo RC: Genomic analyis of human B-lymphotropic virus (HBLV). Science 234: 601-603, 1986.
25. Klotman ME, Lusso P, Bacchus D, Corbellino M, Jarrett RF, Berneman ZN: Detection of human herpesvirus 6 and human herpesvirus 7 by PCR amplification. In: Persing DH, Smith TF, Tenover FC, White TJ: Diagnostic molecular microbiology. Am Soc Microbiol, Washinmgton DC pp. 501-510, 1993.
26. Seyda M, Scheele T, Neumann R, Krueger GRF: Comparative evaluation of non-radioactive in situ hybridization techniques for pathologic diagnosis of virus infection. Path Res Pract 184: 18-26, 1989.
27. Wijsman JH, Jonker RR, Keizer R, van de Velde CJH, Cornelisse CJ, van Dierendonck JH: A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 41: 502-506, 1993.
28. Lane DP, Benchimol S: P53: oncogene or anti-oncogene? Genes and Dev 4: 1-8, 1990.
29. Chen PL, Chen Y, Brookstein R, Lee WH: Genetic mechanisms of tumor suppression bythe human p53 gene. Science 250: 1576-1580, 1990.
30. Yewdell JW, Gannon JV, Lane DP: Monoclonal antibody analysis of p53 expression in normal and transformed cells. J Virol 59: 444-452, 1986.
31. Haffner R, Oren M: Biochemical properties and biological effects of p53. Curr Opinion Genet Dev 5: 84-90, 1995.
32. Cox LS, Lane DP: Tumor suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. Bioassays 17: 501-508, 1995.
33. Chernova OB, Chernov MV, Agarwal ML, Taylor WR, Stark GR: The role of p53 in regulating genomic stability whn DNA and RNA synthesis are inhibited. TIBS 20: 431-434,1995.
34. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
35. Xiong Y, Hannon GJ, Zhang H Casso D, Kobayashi R, Beach D: P21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993.
36. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174, 1994.
37. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC: Introduction to apoptosis by the Bcl-2 homologue Bak. Nature 374: 733-736, 1995.
38. Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonehara M, Yonehara S: Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc. Nat Acad Scis USA 87: 9620-9624, 1990.
39. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Nat Acad Scis USA 88: 6961-6965, 1991.
40. Vaux DL, Cory S, Adams JM: Bcl-2 promotes the survival of hematopoietic cells and cooprates with c-myc to immortalize pre-B cells. Nature 335: 440-442, 1988.
41. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC: Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361: 365-369, 1993.
42. Deliconstantinos G, Krueger GRF: Reactive oxygen species and cell membrane fluidity in human herpesvirus-6 (HHV-6) infected cells. J Viral Dis 1: 22-27, 1993.
43. Buttke TM, Sandstrom PA: Redox regulation of programmed cell death in lymphocytes. Free Rad Res 22: 389-397, 1995.
44. Schonnebeck M, Krueger GRF, Braun M, Fischer M, Koch B, Ablashi DV, Balachandran N: Human herpesvirus-6 infection may predispose cells to superinfection by other viruses. In Vivo 5: 255-264, 1991.
45. Furukawa M, Yasukawa M, Yakushijin Y, Fujita S: Distinct effects of human herpesvirus 6 and human herpesvirus 7 on surface molecule expression and function of CD4+ T cells. J Immunol 152: 5768-5775, 1994.
46. Flamand L, Gosselin J, Ablashi DV, D'Addario M, Hiscott J, Menezes J: Dual effect of human herpesvirus-6 (HHV-6) on mononuclear cells: induction of IL-1a and TNFa, but suppression of IL-6 synthesis. J Virol 65: 5105-5110, 1991.
47. Gosselin J, Flamand L, D'Addario M, Hiscott J, Stefanescu 1, Ablashi DV, Gallo RC, Menezes J: Modulatory effects-of Epstein-Barr virus, herpes simplex and human herpesvirus-6 viral infections and coinfections on cytokine synthesis. J Immunol 149: 181-187, 1992. Kohn A: Early interactions of viruses with cellular membranes. Adv Virus Res 24: 223-275, 1979.
48. Gosselin J, Flamand L, D'Addario M, Hiscott J, Stefanescu 1, Ablashi DV, Gallo RC, Menezes J: Modulatory effects-of Epstein-Barr virus, herpes simplex and human herpesvirus-6 viral infections and coinfections on cytokine synthesis. J Immunol 149: 181-187, 1992. Kohn A: Early interactions of viruses with cellular membranes. Adv Virus Res 24: 223-275, 1979.
49. Krueger GRF, Stolzenburg T, Muller C: Cell mebrane lipid fluidity and receptor expression in Moloney-and Friendvirus-transformed cells. In Vivo 1: 343-346, 1987.
50. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345-347, 1991.
51. Flamand L, Gosselin J, Stefanescu 1, Ablashi D, Menezes J: Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood 85: 1263-1271, 1995.
52. Collins MK, Marvel J, Malde P, Lopez-Rivas A: Interleukin 3 protects murine bone marrow cells from apoptosis inuced by DNA damaging agents. J Exp Med 176: 1043-1051, 1992.
53. Miyazaki T, Liu Z-L, Kawahara A, Minami Y, Yamada K, Tsujimoto Y, Barsoumian EL, Perlmutter RM, Taniguchi T: Three distinct IL-2 signalling pathways mediated by bcl-2, c-myc, and Ick cooperate in hematopoietic cell proliferation. Cell 81: 223-231, 1995.
54. Balkwill FR, Burke F: The cytokine network. Immunol Today 10: 299-304, 1989.
55. Krueger GRF, Buja LM, Rojo J, Lasch J, Koch B, Leyssens N: Apoptose und Zellproliferation bei HHV-6 Infektionen. Pathologe 16: 120-127, 1995.
56. Krueger GRF, Wagner M, Koch B, Leyssens N: Apoptosis and cell proliferation in EBV/HHV-6 positive Kikuchi's lymphadenitis and Hodgkin's disase. FASEB J 10: A1010, 1996.
57. Hsu SM, Xie SS, Hsu PL: Cultured Reed-Sternberg cells HDLM-1 and KMH2 can be inducd to become histiocyte-like cells. Am J Pathol 137: 353-367, 1990.
58. Krueger GRF, Ferrer Argote V: A unifying concept of viral immunopathogenesis of proliferative and aproliferative diseases ( working hypothesis). In Vivo 8: 493-500, 1994.
59. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ: Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374: 736-739, 1995.
60. Heidecker G, Huleihel M, Cleveland JL, Kolch W, Beck P, Lloyd P, Pawson T, Rapp UR: Mutational activation of c-raf-1 and definition of the minimal transforming sequence. Mol Cell Biol 10: 2503-2512, 1990.
61. Oltvai ZN, Millman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
62. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169: 1747-1756, 1989
63. Bos JL: The ras gene family and human carcinogenesis. Mut Res 195: 255-271, 1988.
64. Kanai T, Hirohashi S, Noguchi M, Shimoyama Y, Shimosato Y, Noguchi S, Nishimura S, Abe O: Monoclonal antibody highly sensitive for the detection of ras p21 in immunoblotting analysis. Jpn J Cancer Res 78: 1314-1318, 1987.
65. Sambucetti LC, Curran T: The fos protein complex is associated with DNA in isolated nuclei and binds to DNA cellulose. Science 234: 1417-1419, 1986.
66. Rapp UR, Goldsborough MD, Mark GE, Bonner TI, Groffen J, Reynolds FH, Stephenson JR: Structure an biological activation of v-raf, a unique oncogene transduced by a retrovirus. Proc Nat Acad Scis USA 50: 4218-4222, 1983.
67. Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Path 162: 285-294, 1990.
68. Lee SH, HunNitz J: Mechanism of elongation of primed DNA by DNA polymerase delta, proliferating cell nuclear antigen, and activator 1. Pro Nat Acad Scis USA 87: 5672-5676, 1990.
69. Won K, Xiong Y, Beach D, Gilman MZ: Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc Nat Acad Scis USA 89: 9910-9911, 1992.
70. Xiong Y, Conolly T, Futcher B, Beach D: Human D-type cyclin. Cell 15: 691-699, 1991.
71. Cohen DR, Ferreira CD, Gentz R, Franza BR Jr, Curran T: The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with jun: transcription factor AP-1 is comprised of multiple protein complexes. Genes and Dev 3: 173-184, 1989.